Application of the Crystal Structure of the SARS-CoV-2 Spike Protein for the Development of a Peptide Vaccine against Virus

Capa

Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Based on the spike protein of the SARS-CoV-2 virus, a protein capable of causing an immune answer has been predicted. The protein stability in solution is confirmed by the molecular dynamics simulation. Immunomodulation has shown that this protein causes an immune reaction and, correspondingly, may serve a vaccine prototype.

Sobre autores

A. Ivanovsky

Shubnikov Institute of Crystallography, Federal Scientific Research Centre “Crystallography and Photonics,” Russian Academy of Sciences, 119333, Moscow, Russia

Email: a.1wanowskiy@gmail.com
Россия, Москва

I. Kolesnikov

National Research Centre “Kurchatov Institute”, 123182, Moscow, Russia

Email: a.1wanowskiy@gmail.com
Россия, Москва

Yu. Kordonskaya

National Research Centre “Kurchatov Institute”, 123182, Moscow, Russia; Shubnikov Institute of Crystallography, Federal Scientific Research Centre “Crystallography and Photonics,” Russian Academy of Sciences, 119333, Moscow, Russia

Email: a.1wanowskiy@gmail.com
Россия, Москва; Россия, Москва

A. Ermakov

National Research Centre “Kurchatov Institute”, 123182, Moscow, Russia

Email: a.1wanowskiy@gmail.com
Россия, Москва

M. Marchenkova

National Research Centre “Kurchatov Institute”, 123182, Moscow, Russia; Shubnikov Institute of Crystallography, Federal Scientific Research Centre “Crystallography and Photonics,” Russian Academy of Sciences, 119333, Moscow, Russia

Email: a.1wanowskiy@gmail.com
Россия, Москва; Россия, Москва

V. Timofeev

National Research Centre “Kurchatov Institute”, 123182, Moscow, Russia; Shubnikov Institute of Crystallography, Federal Scientific Research Centre “Crystallography and Photonics,” Russian Academy of Sciences, 119333, Moscow, Russia

Email: a.1wanowskiy@gmail.com
Россия, Москва; Россия, Москва

Yu. Pisarevsky

Shubnikov Institute of Crystallography, Federal Scientific Research Centre “Crystallography and Photonics,” Russian Academy of Sciences, 119333, Moscow, Russia; National Research Centre “Kurchatov Institute”, 123182, Moscow, Russia

Email: a.1wanowskiy@gmail.com
Россия, Москва; Россия, Москва

Yu. Dyakova

National Research Centre “Kurchatov Institute”, 123182, Moscow, Russia

Email: a.1wanowskiy@gmail.com
Россия, Москва

M. Kovalchuk

National Research Centre “Kurchatov Institute”, 123182, Moscow, Russia; Shubnikov Institute of Crystallography, Federal Scientific Research Centre “Crystallography and Photonics,” Russian Academy of Sciences, 119333, Moscow, Russia

Autor responsável pela correspondência
Email: a.1wanowskiy@gmail.com
Россия, Москва; Россия, Москва

Bibliografia

  1. Chan J.F.-W., Yuan S., Kok K.-H. et al. // Lancet. 2020. V. 395. № 10223. P 514. https://doi.org/10.1016/S0140-6736(20)30154-9
  2. Zhu N., Zhang D., Wang W. et al. // N. Engl. J. Med. 2020. V. 382. P. 727. https://doi.org/10.1056/NEJMoa2001017
  3. WHO (2020) Coronavirus Disease (COVID-19) Dashboard. World Heal. Organ.
  4. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance, WHO, 2020, 28 January.
  5. Randhawa G.S., Soltysiak M.P.M., El Roz H. et al. // PLoS ONE. 2020. V. 16 (1). E. 0232391. https://doi.org/10.1371/journal.pone.0232391
  6. Dongwan K., Lee J.-Y., Yang J.-S. et al. // Cell. 2020. V. 181. № 4. P. 914. https://doi.org/10.1016/j.cell.2020.04.011
  7. WHO Draft Landscape of COVID-19 Candidate Vaccines. WHO, Geneva-2020.
  8. Smith Trevor R.F., Patel A., Ramos S. et al. // Nat. Commun. 2020. V. 11. P. 2610. https://doi.org/10.1038/s41467-020-16505-0
  9. Mulligan Mark J., Lyke K.E., Kitchin N. et al. // Nature. 2020. V. 586. P. 589. https://doi.org/10.1038/s41586-020-2639-4
  10. Zhu F.-C., Guan X.-H., Li Y.-H. et al. // Lancet. 2020. V. 396. № 10249. P. 479. https://doi.org/10.1016/S0140-6736(20)31605-6
  11. Gao Q., Bao L., Mao H. et al. // Science. 2020. V. 369. № 6499. P. 77.
  12. Cao Y., Yisimayi A., Jian F. et al. // Nature. 2022. V. 608. P. 593. https://doi.org/10.1038/s41586-022-04980-y
  13. Gallagher T.M., Buchmeier M.J. // Virology. 2001. V. 279. № 2. P. 371. https://doi.org/10.1006/viro.2000.0757
  14. https://pymol.org/2/
  15. Abraham M.J., Murtola T., Schulz R. et al. // SoftwareX. 2015. V. 1. P. 19. https://doi.org/10.1016/j.softx.2015.06.001
  16. Lindorff-Larsen K., Piana S., Palmo K. et al. // Proteins. 2010. V. 78. P. 1950. https://doi.org/10.1002/prot.22711
  17. Berendsen H.J.C., Postma J.P.M., van Gunsteren W.F. et al. // J. Chem. Phys. 1984. V. 81. № 8. P. 3684. https://doi.org/10.1063/1.448118
  18. Parrinello M., Rahman A. // J. Chem. Phys. 1982. V. 76. № 5. P. 2662. https://doi.org/10.1063/1.443248
  19. Hess B., Bekker H., Herman J.C. et al. // J. Comput. Chem. 1997. V. 18. P. 1463. https://doi.org/10.1002/(SICI)1096
  20. Darden T., York D., Pedersen L. // J. Chem. Phys. 1993. V. 98. № 12. P. 10089. https://doi.org/10.1063/1.464397
  21. https://kraken.iac.rm.cnr.it/C-IMMSIM/index.php
  22. Luckheeram R.V., Zhou R., Verma A.D., Xia B. // J. Immunol. Res. 2012. Art. 925135. https://doi.org/10.1155/2012/925135
  23. Rapin N., Lund O., Bernaschi M., Castiglione F. // PubMed. 2010. https://doi.org/10.1371/journal.pone.000986

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar
2.

Baixar (470KB)
Metadados
3.

Baixar (504KB)
Metadados

Declaração de direitos autorais © Russian Academy of Sciences, 2023